Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 47151-47200 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05525845
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
NARecruiting
15 participants
Started: Sep 8, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT05935722
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
NARecruiting
60 participants
Started: Sep 8, 2022 · Completed: Jun 30, 2026
3 conditions6 sponsors5 locations
NCT05651204
GABA Biomarkers in Dravet Syndrome
N/ARecruiting
36 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2027
1 condition2 sponsors1 location
NCT06342206
The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools
N/ARecruiting
24 participants
Started: Sep 8, 2022 · Completed: Mar 27, 2025
1 condition1 sponsor1 location
NCT05564091
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
NARecruiting
78 participants
Started: Sep 8, 2022 · Completed: Jul 31, 2027
1 condition2 sponsors4 locations
NCT05580315
EPOS Discoid Meniscus (DiMe) Project
N/ARecruiting
500 participants
Started: Sep 8, 2022 · Completed: Sep 1, 2042
1 condition1 sponsor12 locations
NCT05169593
Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy
PHASE4Recruiting
292 participants
Started: Sep 8, 2022 · Completed: Oct 31, 2030
1 condition1 sponsor28 locations
NCT05007990
Caregiving Networks Across Disease Context and the Life Course
N/ARecruiting
2,800 participants
Started: Sep 8, 2022 · Completed: Dec 31, 2030
5 conditions1 sponsor1 location
NCT06320626
Pharmacokinetic-guided Dosing of Emicizumab
PHASE4Recruiting
95 participants
Started: Sep 8, 2022 · Completed: Aug 31, 2026
6 conditions9 sponsors8 locations
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
PHASE3Recruiting
1,594 participants
Started: Sep 8, 2022 · Completed: Apr 30, 2032
1 condition2 sponsors207 locations
NCT05619250
Supervised Center-based vs. Unsupervised Home-based Exercise Programs (PRO-Training)
NARecruiting
120 participants
Started: Sep 7, 2022 · Completed: Dec 20, 2024
3 conditions3 sponsors1 location
NCT05497531
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
NARecruiting
15 participants
Started: Sep 7, 2022 · Completed: Jun 30, 2025
6 conditions1 sponsor1 location
NCT05385549
5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk
PHASE2Recruiting
35 participants
Started: Sep 7, 2022 · Completed: Apr 30, 2030
1 condition1 sponsor1 location
NCT05618041
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
NARecruiting
50 participants
Started: Sep 7, 2022 · Completed: Dec 6, 2027
3 conditions2 sponsors1 location
NCT05556642
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
N/ARecruiting
500 participants
Started: Sep 7, 2022 · Completed: Sep 1, 2040
2 conditions1 sponsor1 location
NCT05330338
Genetics of Ventriculo-arterial Discordance
NARecruiting
600 participants
Started: Sep 7, 2022 · Completed: Jun 30, 2045
1 condition4 sponsors16 locations
NCT05563805
Exploring Virtual Reality Adventure Training Exergaming
NARecruiting
40 participants
Started: Sep 7, 2022 · Completed: Aug 31, 2025
7 conditions1 sponsor1 location
NCT05534412
A Practice-Based Intervention to Improve Care for a Diverse Population of Women with Urinary Incontinence
NARecruiting
1,600 participants
Started: Sep 7, 2022 · Completed: Feb 28, 2026
1 condition6 sponsors4 locations
NCT05213598
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
N/ARecruiting
100 participants
Started: Sep 7, 2022 · Completed: Jun 30, 2051
1 condition1 sponsor1 location
NCT05761093
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
N/ARecruiting
306 participants
Started: Sep 7, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05419037
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
N/ARecruiting
90 participants
Started: Sep 7, 2022 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05322629
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
NARecruiting
650 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05424562
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada
N/ARecruiting
270 participants
Started: Sep 7, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor20 locations
NCT05412927
AngelMed Guardian® System PMA Post Approval Study
N/ARecruiting
500 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor18 locations
NCT05277818
Post-marketing Clinical Follow-up of the Medical Device DIVA®
N/ARecruiting
822 participants
Started: Sep 7, 2022 · Completed: Mar 15, 2027
1 condition1 sponsor1 location
NCT05604495
Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis
N/ARecruiting
1,000 participants
Started: Sep 7, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05288842
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
N/ARecruiting
102 participants
Started: Sep 6, 2022 · Completed: Oct 31, 2026
2 conditions6 sponsors1 location
NCT04987541
The Therapeutic Effect of TBS Stimulation on Emotion Regulation in Autism Spectrum Disorder
NARecruiting
60 participants
Started: Sep 6, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05598203
Effect of Nutrition Education Groups in the Treatment of Patients with Type 2 Diabetes
NARecruiting
252 participants
Started: Sep 6, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor2 locations
NCT05319132
Evaluate DF-003 in ex Vivo Assays Using Peripheral Blood Mononuclear Cell From Subjects With ROSAH Syndrome
N/ARecruiting
4 participants
Started: Sep 6, 2022 · Completed: May 6, 2028
1 condition1 sponsor5 locations
NCT05529251
De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
PHASE2Recruiting
90 participants
Started: Sep 6, 2022 · Completed: Sep 6, 2030
2 conditions1 sponsor15 locations
NCT06118567
Effect of Nitrous Oxide on Aggression.
PHASE2Recruiting
50 participants
Started: Sep 6, 2022 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT05990179
Genomic Uniformed-Screening Against Rare Disease In All Newborns
NARecruiting
100,000 participants
Started: Sep 6, 2022 · Completed: Sep 30, 2029
1 condition4 sponsors1 location
NCT05423717
Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder
PHASE2Recruiting
150 participants
Started: Sep 6, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor52 locations
NCT05534438
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
PHASE2Recruiting
40 participants
Started: Sep 6, 2022 · Completed: Sep 6, 2026
6 conditions1 sponsor8 locations
NCT05422560
Preoperative Embolization of the Inferior Mesenteric Artery in Colorectal Surgery
NARecruiting
30 participants
Started: Sep 6, 2022 · Completed: May 31, 2025
1 condition3 sponsors3 locations
NCT05544097
Spectral Analysis of Bowel Sounds in Preterm Babies of Less Than 32 Weeks of Amenorrhea (WA) as Predictive Factor of Enterocolitis
NARecruiting
50 participants
Started: Sep 6, 2022 · Completed: Nov 30, 2025
4 conditions1 sponsor1 location
NCT06014528
IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer
PHASE2Recruiting
168 participants
Started: Sep 6, 2022 · Completed: Dec 24, 2026
1 condition1 sponsor1 location
NCT05334368
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
PHASE3Recruiting
123 participants
Started: Sep 6, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor78 locations
NCT04971499
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
PHASE1/PHASE2Recruiting
26 participants
Started: Sep 6, 2022 · Completed: Apr 30, 2026
1 condition3 sponsors1 location
NCT05294107
Intestinal Organoids
NARecruiting
90 participants
Started: Sep 6, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT05535543
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
N/ARecruiting
60 participants
Started: Sep 6, 2022 · Completed: Feb 28, 2025
3 conditions1 sponsor1 location
NCT05489211
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
PHASE2Recruiting
582 participants
Started: Sep 6, 2022 · Completed: Aug 19, 2026
7 conditions2 sponsors95 locations
NCT05054738
CRP and S&A for Inpatient Veterans
NARecruiting
195 participants
Started: Sep 6, 2022 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT05466006
Peri-implant Soft Tissue Volume Changes at Small Buccal Dehiscences
NARecruiting
28 participants
Started: Sep 5, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05337566
Does Additional Use of Preoperative Azithromycin Decrease Posthysterectomy Infections
NARecruiting
2,278 participants
Started: Sep 5, 2022 · Completed: Dec 31, 2030
4 conditions6 sponsors6 locations
NCT05264259
New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
N/ARecruiting
100 participants
Started: Sep 5, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05264389
Post-market Clinical Follow-up (PMCF) Study of the Poly-Tape Devices for Medial Patellofemoral Ligament (MPFL) Reconstruction
N/ARecruiting
55 participants
Started: Sep 5, 2022 · Completed: Sep 30, 2031
1 condition1 sponsor5 locations
NCT05536089
ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation
N/ARecruiting
2,000 participants
Started: Sep 5, 2022 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05449002
Digital Single Session Intervention for Youth Mental Health
NARecruiting
226 participants
Started: Sep 5, 2022 · Completed: Sep 30, 2027
4 conditions1 sponsor5 locations